The Latest
Is HIV Itself a Marker for Worse COVID-19 Outcomes? Research Remains Mixed
Over a year into the COVID-19 pandemic, clinicians’ worst fears about HIV and COVID-19 don’t appear to have materialized—but there remains a lot of uncertainty.
Recent Research Highlights Difficulty in Measuring Heart Disease Risk for People Living With HIV
Two studies out of Europe aimed to give data on which patients with HIV benefit most from lipid-lowering medications, but they both ultimately concluded that better CVD risk-assessment tools—targeted specifically for PLWH—are needed.
This Week in HIV Research: The Importance of Challenging Our Assumptions
Feb. 25, 2021: High HCV SVR among people using substances; geographic HIV care disparities among Black Americans; self-administered imiquimod vs. ASIL excision; PrEP uptake in syringe service programs.
This Week in HIV Research: To Sleep, Perchance to Dream
Feb. 18, 2021: Insomnia rates among PLWH; trends in multimorbidity diagnosis; viral load control loss in the modern HIV treatment era; acceptability of HIV self-test dissemination methods.
This Week in HIV Research: Early Screening Matters, and Not Just for HIV
Feb. 11, 2021: Early comorbidity development among women living with HIV; type 2 heart attack frequency; assessing European-based CVD assessment tools; long-term cognitive dysfunction and HIV/hepatitis coinfection.
This Week in HIV Research: What Risk Compensation?
Feb. 4, 2021: STI rates among PrEP users; how Medicaid expansion affects HIV testing and PrEP rates; utilizing mental health care providers in PrEP uptake; adapting HIV care in the COVID era.
Elevated Dementia Risk Persists Among Older People Living With HIV
Even among people on modern HIV treatment, just over a quarter of PLWH are diagnosed with dementia by age 80, compared to just under 14% of HIV-negative people, according to a new U.S. study.
This Week in HIV Research: Health in Unity
Jan. 21, 2021: Dyad-level interventions in serodiscordant relationships; using social media to improve PrEP uptake; HCV prevalence among MSM; the irrelevance of doxycycline prophylaxis against mycoplasma genitalium.
This Week in HIV Research: A Patient’s History Really Matters
Jan. 14, 2021: Interpersonal violence history and adverse HIV outcomes; the incidence and severity of breast cancer; the effect of menopause on integrase-associated weight gain; two-drug therapy for HIV treatment-experienced people.
This Week in HIV Research: Delivering Care Through Uncertainty
Jan. 7, 2021: HIV status and COVID-19 disease severity; associations between tobacco smoking, cancer incidence, viral load, and CD4 count; immune recovery on integrase inhibitors; using smart pill bottles to boost adherence.